Quick Answer
VYCOR MEDICAL INC reported Total Revenue of $1.86 million for fiscal year 2025.
VYCOR MEDICAL INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.86M +17.2% |
$1.59M +8.8% |
$1.46M +19.4% |
$1.22M -12.2% |
$1.39M +22.0% |
$1.14M -18.0% |
| Revenue (ASC 606) | $1.86M +17.2% |
$1.59M +8.8% |
$1.46M +19.4% |
$1.22M -12.2% |
$1.39M +22.0% |
$1.14M -18.0% |
| Net Income | -$72.4K +32.4% |
-$107.2K -53.8% |
-$69.7K +82.8% |
-$404.9K +7.1% |
-$435.7K +47.0% |
-$822.5K -3.3% |
| Diluted EPS | -$0.01 +0.0% |
-$0.01 +0.0% |
-$0.01 +50.0% |
-$0.02 | — | — |
| Total Assets | $830.4K -16.8% |
$998.1K +0.6% |
$992.3K +15.4% |
$860.2K -8.0% |
$935.4K -5.2% |
$986.5K -9.7% |
| Cash and Equivalents | $87.0K -17.7% |
$105.6K +84.4% |
$57.3K +54.7% |
$37.0K -59.3% |
$90.9K +97.7% |
$46.0K -24.2% |
| Long-Term Debt | — | — | — | — | $150.0K +0.0% |
$150.0K |
| Stockholders Equity | -$4.09M -10.8% |
-$3.69M -11.0% |
-$3.33M -13.1% |
-$2.94M -222.8% |
$2.40M +220.9% |
-$1.98M -46.3% |
| R&D Expense | $10.0K -35.0% |
$15.3K -32.1% |
$22.6K | — | $15.2K | — |
| Operating Income | $33.9K +470.7% |
-$9.1K -122.8% |
$40.2K +113.1% |
-$306.5K +29.7% |
-$436.0K +40.1% |
-$727.4K -21.0% |
| Gross Profit | $1.56M +9.7% |
$1.42M +8.1% |
$1.32M +21.6% |
$1.08M -14.0% |
$1.26M +24.6% |
$1.01M -19.8% |
| Shares Outstanding | 33.37M +0.0% |
33.37M +2.3% |
32.63M +0.3% |
32.53M +5.5% |
30.82M +12.3% |
27.43M +8.5% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $513.8K | +31.5% | +3.5% |
| Revenue (ASC 606) | September 30, 2025 | $513.8K | +31.5% | +3.5% |
| Net Income | September 30, 2025 | $4.9K | +108.3% | -79.3% |
| Diluted EPS | September 30, 2025 | $0.00 | +100.0% | — |
| Total Assets | September 30, 2025 | $941.2K | -12.4% | +7.1% |
| Cash and Equivalents | September 30, 2025 | $64.2K | -59.3% | -35.6% |
| Long-Term Debt | September 30, 2021 | $150.0K | — | +0.0% |
| Stockholders Equity | September 30, 2025 | -$4.02M | -9.3% | -4.1% |
| R&D Expense | June 30, 2025 | $4.2K | +85.6% | -27.1% |
| Operating Income | September 30, 2025 | $32.1K | +191.3% | -37.3% |
| Gross Profit | September 30, 2025 | $451.9K | +27.6% | +8.8% |
| Shares Outstanding | September 30, 2025 | 33.37M | +0.0% | +0.0% |
- VYCOR MEDICAL INC reported Total Revenue of $1.86 million for fiscal year 2025.
- VYCOR MEDICAL INC showed an increase of +17.2% in Total Revenue compared to the prior fiscal year.
- VYCOR MEDICAL INC reported Revenue (ASC 606) of $1.86 million for fiscal year 2025.
- VYCOR MEDICAL INC showed an increase of +17.2% in Revenue (ASC 606) compared to the prior fiscal year.
- VYCOR MEDICAL INC reported Net Income of -$72.4 thousand for fiscal year 2025.
- VYCOR MEDICAL INC showed an increase of +32.4% in Net Income compared to the prior fiscal year.
- VYCOR MEDICAL INC reported Diluted EPS of $0.01 per share (loss) for fiscal year 2025.
- VYCOR MEDICAL INC showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- VYCOR MEDICAL INC reported Total Assets of $830.4 thousand for fiscal year 2025.
- VYCOR MEDICAL INC showed a decrease of -16.8% in Total Assets compared to the prior fiscal year.
- VYCOR MEDICAL INC reported Cash and Equivalents of $87.0 thousand for fiscal year 2025.
- VYCOR MEDICAL INC showed a decrease of -17.7% in Cash and Equivalents compared to the prior fiscal year.
- VYCOR MEDICAL INC reported Long-Term Debt of $150.0 thousand for fiscal year 2021.
- VYCOR MEDICAL INC showed an increase of +0.0% in Long-Term Debt compared to the prior fiscal year.
- VYCOR MEDICAL INC reported Stockholders Equity of -$4.09 million for fiscal year 2025.
- VYCOR MEDICAL INC showed a decrease of -10.8% in Stockholders Equity compared to the prior fiscal year.
- VYCOR MEDICAL INC reported R&D Expense of $10.0 thousand for fiscal year 2025.
- VYCOR MEDICAL INC showed a decrease of -35.0% in R&D Expense compared to the prior fiscal year.
- VYCOR MEDICAL INC reported Operating Income of $33.9 thousand for fiscal year 2025.
- VYCOR MEDICAL INC showed an increase of +470.7% in Operating Income compared to the prior fiscal year.
- VYCOR MEDICAL INC reported Gross Profit of $1.56 million for fiscal year 2025.
- VYCOR MEDICAL INC showed an increase of +9.7% in Gross Profit compared to the prior fiscal year.
- VYCOR MEDICAL INC reported Shares Outstanding of 33.37 million shares for fiscal year 2025.
- VYCOR MEDICAL INC showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: